|
[1]
|
Sathe, G., Deepha, S., Gayathri, N., Nagappa, M., Parayil Sankaran, B., Taly, A.B., et al. (2021) Ethylmalonic Encephalopathy ETHE1 p. D165H Mutation Alters the Mitochondrial Function in Human Skeletal Muscle Proteome. Mitochondrion, 58, 64-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Mineri, R., Rimoldi, M., Burlina, A.B., Koskull, S., Perletti, C., Heese, B., et al. (2008) Identification of New Mutations in the ETHE1 Gene in a Cohort of 14 Patients Presenting with Ethylmalonic Encephalopathy. Journal of Medical Genetics, 45, 473-478. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Platt, I., Bisgin, A. and Kilavuz, S. (2023) Ethylmalonic Encephalopathy: A Literature Review and Two New Cases of Mild Phenotype. Neurological Sciences, 44, 3827-3852. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
García-Silva, M.T., Ribes, A., Campos, Y., Garavaglia, B. and Arenas, J. (1997) Syndrome of Encephalopathy, Petechiae, and Ethylmalonic Aciduria. Pediatric Neurology, 17, 165-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kabil, O. and Banerjee, R. (2012) Characterization of Patient Mutations in Human Persulfide Dioxygenase (ETHE1) Involved in H2S Catabolism. Journal of Biological Chemistry, 287, 44561-44567. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Amaral, A.U., Cecatto, C., Busanello, E.N.B., Ribeiro, C.A.J., Melo, D.R., Leipnitz, G., et al. (2012) Ethylmalonic Acid Impairs Brain Mitochondrial Succinate and Malate Transport. Molecular Genetics and Metabolism, 105, 84-90. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Grings, M., Wajner, M. and Leipnitz, G. (2020) Mitochondrial Dysfunction and Redox Homeostasis Impairment as Pathomechanisms of Brain Damage in Ethylmalonic Encephalopathy: Insights from Animal and Human Studies. Cellular and Molecular Neurobiology, 42, 565-575. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Sahebekhtiari, N., Fernandez-Guerra, P., Nochi, Z., Carlsen, J., Bross, P. and Palmfeldt, J. (2019) Deficiency of the Mitochondrial Sulfide Regulator ETHE1 Disturbs Cell Growth, Glutathione Level and Causes Proteome Alterations Outside Mitochondria. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1865, 126-135. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ritter, L., Kleemann, D., Hickmann, F.H., Amaral, A.U., Sitta, Â., Wajner, M., et al. (2015) Disturbance of Energy and Redox Homeostasis and Reduction of Na+, K+-ATPase Activity Provoked by in Vivo Intracerebral Administration of Ethylmalonic Acid to Young Rats. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1852, 759-767. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bhat, M.D., Prasad, C., Tiwari, S., Chandra, S.R. and Christopher, R. (2016) Diffusion Restriction in Ethylmalonic Encephalopathy—An Imaging Evidence of the Pathophysiology of the Disease. Brain and Development, 38, 768-771. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Giordano, C., Viscomi, C., Orlandi, M., Papoff, P., Spalice, A., Burlina, A., et al. (2011) Morphologic Evidence of Diffuse Vascular Damage in Human and in the Experimental Model of Ethylmalonic Encephalopathy. Journal of Inherited Metabolic Disease, 35, 451-458. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Dionisi-Vici, C., Diodato, D., Torre, G., Picca, S., Pariante, R., Giuseppe Picardo, S., et al. (2016) Liver Transplant in Ethylmalonic Encephalopathy: A New Treatment for an Otherwise Fatal Disease. Brain, 139, 1045-1051. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Cooper, C.E. and Brown, G.C. (2008) The Inhibition of Mitochondrial Cytochrome Oxidase by the Gases Carbon Monoxide, Nitric Oxide, Hydrogen Cyanide and Hydrogen Sulfide: Chemical Mechanism and Physiological Significance. Journal of Bioenergetics and Biomembranes, 40, 533-539. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Tiranti, V. (2005) ETHE1 Mutations Are Specific to Ethylmalonic Encephalopathy. Journal of Medical Genetics, 43, 340-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Tam, A., AlDhaheri, N.S., Mysore, K., Tessier, M.E., Goss, J., Fernandez, L.A., et al. (2019) Improved Clinical Outcome Following Liver Transplant in Patients with Ethylmalonic Encephalopathy. American Journal of Medical Genetics Part A, 179, 1015-1019. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
张开慧, 黄艳, 盖中涛, 等. 一例非典型乙基丙二酸脑病患儿的临床及遗传学分析[J]. 中华医学遗传学杂志, 2018, 35(5): 694-698.
|
|
[17]
|
Tiranti, V., Viscomi, C., Hildebrandt, T., Di Meo, I., Mineri, R., Tiveron, C., et al. (2009) Loss of ETHE1, a Mitochondrial Dioxygenase, Causes Fatal Sulfide Toxicity in Ethylmalonic Encephalopathy. Nature Medicine, 15, 200-205. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Di Meo, I., Fagiolari, G., Prelle, A., Viscomi, C., Zeviani, M. and Tiranti, V. (2011) Chronic Exposure to Sulfide Causes Accelerated Degradation of Cytochrome C Oxidase in Ethylmalonic Encephalopathy. Antioxidants & Redox Signaling, 15, 353-362. [Google Scholar] [CrossRef] [PubMed]
|